XML 23 R12.htm IDEA: XBRL DOCUMENT v3.19.2
Stock-Based Compensation
3 Months Ended
May 04, 2019
Share Based Compensation [Abstract]  
Stock-Based Compensation

Note 5 - Stock-Based Compensation

At our 2017 annual meeting of shareholders held on June 13, 2017, our shareholders approved a new equity incentive plan, the Shoe Carnival, Inc. 2017 Equity Incentive Plan (the “2017 Plan”), which replaced our 2000 Stock Option and Incentive Plan, as amended (the “2000 Plan”).  We may issue stock options, stock appreciation rights, restricted stock, stock units and other stock-based awards to eligible participants under the 2017 Plan.  According to the terms of the 2017 Plan, upon approval of the 2017 Plan by our shareholders, no further awards may be made under the 2000 Plan.  A maximum of 1,000,000 shares of our common stock are available for issuance and sale under the 2017 Plan.  In addition, any shares of our common stock subject to an award granted under the 2017 Plan, or to an award granted under the 2000 Plan that was outstanding on the date our shareholders approved the 2017 Plan, that expires, is cancelled or forfeited, or is settled for cash will, to the extent of such cancellation, forfeiture, expiration or cash settlement, automatically become available for future awards under the 2017 Plan.

Stock-based compensation includes stock options, cash-settled stock appreciation rights, restricted stock awards, restricted stock units and performance stock units. Additionally, we recognize stock-based compensation expense for the discount on shares sold to employees through our employee stock purchase plan. Stock-based compensation expense for the employee stock purchase plan was $11,000 before the income tax benefit of $1,000 and $11,000 before the income tax benefit of $3,000 for the thirteen weeks ended May 4, 2019, and May 5, 2018, respectively.

Restricted Stock

The following table summarizes transactions for our restricted stock awards pursuant to our stock-based compensation plans:

 

 

 

Number of

Shares

 

 

Weighted-

Average Grant

Date Fair Value

 

Restricted stock at February 2, 2019

 

 

825,281

 

 

$

23.94

 

Vested

 

 

(708,367

)

 

 

23.88

 

Forfeited or expired

 

 

(40,859

)

 

 

24.26

 

Restricted stock at May 4, 2019

 

 

76,055

 

 

$

24.27

 

 

There were no restricted stock awards granted during the thirteen-week periods ended May 4, 2019 or May 5, 2018. The total fair value at grant date of restricted stock awards that vested during the first quarter of fiscal 2019 was $16.9 million. The total fair value at grant date of restricted stock awards that vested during the first quarter of fiscal 2018 was $887,000.

As of May 4, 2019, approximately $460,000 of unrecognized compensation expense remained related to both our performance-based and service-based restricted stock awards. The cost is expected to be recognized over a weighted average period of approximately 0.9 years.

The following table summarizes transactions for our restricted stock units and performance stock units pursuant to the 2017 Plan:

 

 

 

Number of

Shares

 

 

Weighted-

Average Grant

Date Fair Value

 

Restricted stock units and performance stock units at February 2, 2019

 

 

202,667

 

 

$

24.98

 

Granted

 

 

181,300

 

 

 

31.36

 

Vested

 

 

(86,093

)

 

$

23.27

 

Forfeited

 

 

(2,376

)

 

 

23.27

 

Restricted stock units and performance stock units at May 4, 2019

 

 

295,498

 

 

$

29.41

 

 

As of May 4, 2019, approximately $7.2 million of unrecognized compensation expense remained related to both our restricted stock units and performance stock units. The cost is expected to be recognized over a weighted average period of approximately 1.4 years.

The following table summarizes information regarding stock-based compensation expense recognized for restricted stock awards, restricted stock units and performance stock units:

 

(In thousands)

 

Thirteen Weeks

Ended May 4,

2019

 

 

Thirteen Weeks

Ended May 5,

2018

 

Stock-based compensation expense before the recognized

   income tax benefit

 

$

1,938

 

 

$

1,115

 

Income tax benefit

 

$

247

 

 

$

279

 

Cash-Settled Stock Appreciation Rights

Our cash-settled stock appreciation rights (“SARs”) were granted during the first quarter of fiscal 2019 to certain non-executive employees and will vest and become fully exercisable on March 31, 2020. Any unexercised SARs will expire on March 31, 2022.  Each SAR entitles the holder, upon exercise of their vested shares, to receive cash in an amount equal to the closing price of our stock on the date of exercise less the exercise price, with a maximum amount of gain defined.  The SARs granted during the first quarter of fiscal 2019 were issued with a defined maximum gain of $10.00 over the exercise price of $34.95.  

During the first quarter of fiscal 2015, SARs were granted to certain non-executive employees, such that one-third of the shares underlying the SARs vested and became fully exercisable on each of the first three anniversaries of the date of the grant and were assigned a five-year term from the date of grant, after which any unexercised SARs would expire.  Each SAR entitled the holder, upon exercise of their vested shares, to receive cash in an amount equal to the closing price of our stock on the date of exercise less the exercise price, with a defined maximum gain of $10.00 over the exercise price of $24.26.  During the second quarter of fiscal 2018, all remaining SARs granted during the first quarter of fiscal 2015 were exercised.

The following table summarizes the SARs activity:

 

 

 

Number of

Shares

 

 

Weighted-

Average

Exercise Price

 

 

Weighted-

Average

Remaining

Contractual Term (Years)

 

Outstanding at February 2, 2019

 

 

0

 

 

$

0.00

 

 

 

 

 

Granted

 

 

43,900

 

 

 

34.95

 

 

 

 

 

Forfeited

 

 

0

 

 

 

0.00

 

 

 

 

 

Exercised

 

 

0

 

 

 

0.00

 

 

 

 

 

Outstanding at May 4, 2019

 

 

43,900

 

 

$

34.95

 

 

 

0.9

 

The fair value of these liability awards will be remeasured, using a trinomial lattice model, at each reporting period until the date of settlement. Increases or decreases in stock-based compensation expense are recognized over the vesting period, or immediately for vested awards. The weighted-average fair value of outstanding, non-vested SAR awards as of May 4, 2019 was $5.55.

The fair value was estimated using a trinomial lattice model with the following assumptions:

 

 

 

May 4, 2019

 

 

May 5, 2018

 

Risk free interest rate yield curve

 

2.30% - 2.42%

 

 

1.67% - 2.78%

 

Expected dividend yield

 

0.9%

 

 

1.3%

 

Expected volatility

 

47.95%

 

 

39.74%

 

Maximum life

 

2.9 Years

 

 

1.9 Years

 

Exercise multiple

 

 

1.29

 

 

 

1.34

 

Maximum payout

 

$

10.00

 

 

$

10.00

 

Employee exit rate

 

2.2% - 9.0%

 

 

2.2% - 9.0%

 

 

The risk free interest rate was based on the U.S. Treasury yield curve in effect at the end of the reporting period. The expected dividend yield was based on our historical quarterly cash dividends, with the assumption that quarterly dividends would continue at that rate. Expected volatility was based on the historical volatility of our common stock. The exercise multiple and employee exit rate were based on historical option data.

The following table summarizes information regarding stock-based compensation expense recognized for SARs:

 

(In thousands)

 

Thirteen Weeks

Ended May 4,

2019

 

 

Thirteen Weeks

Ended May 5,

2018

 

Stock-based compensation expense before the recognized

   income tax benefit

 

$

8

 

 

$

65

 

Income tax benefit

 

$

1

 

 

$

16